"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor - PubMed (original) (raw)

"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor

David H Molyneux et al. PLoS Med. 2005 Nov.

Abstract

Controlling seven tropical infections in Africa would cost just 40 cents per person per year, and would permanently benefit hundreds of millions of people.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: DHM is supported by the UK Department for International Development and GlaxoSmithKline (London, United Kingdom) and participates in the Mectizan Expert Committee/Albendazole Coordination meetings, which are supported by Merck and Company (Whitehouse Station, New Jersey, United States of America) and GlaxoSmithKline. JH is an inventor on an international patent application (PCT/US02/33106; filed 11 November, 2002) entitled “Hookworm Vaccine.” PJH is also Co-Chair of the Scientific Advisory Council of the Sabin Vaccine Institute (New Canaan, Connecticut, United States of America) and a member of the Academic Advisory Board for the Pfizer Fellowships in Infectious Diseases. AF is Director of the Schistosomiasis Control Initiative, which is supported by the Bill and Melinda Gates Foundation (Seattle, Washington, United States of America).

Figures

Figure 1

Figure 1. Geographic Overlap of the Neglected Tropical Diseases

(Figure: Molly Brady, Emory University)

Figure 2

Figure 2. Range of Treatment Costs Per Year

References

    1. Molyneux DH. “Neglected” diseases but unrecognised successes—Challenges and opportunities for infectious disease control. Lancet. 2004;364:380–383. - PubMed
    1. Hotez PJ, Remme H, Buss P, Alleyne G, Morel C, et al. Combating tropical communicable diseases: Workshop report of the disease control priorities project. Clin Infec Dis. 2004;38:871–878. - PubMed
    1. Hotez PJ, Ottesen E, Fenwick A, Molyneux DH. The neglected tropical diseases: The ancient afflictions of stigma and poverty and the prospects for their integrated control and elimination. In: Pollard AJ, Finn A, editors. Hot topics in infection and immunity in children III. New York: Kluwer Academic/Plenum Publishers; 2006. In press.
    1. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: Progress in global programme development. Ann Trop Med Parasitol. 2002;96(Suppl 2):S15–S40. - PubMed
    1. Mecaskey JW, Knirsch CA, Kumaresan JA, Cook JA. The possibility of eliminating blinding trachoma. Lancet Infect Dis. 2003;3:728–734. - PubMed

MeSH terms

LinkOut - more resources